I remember that part of the deal of the sale of neoprobe GDS business was "up to 20M$" in royalties based on Devicore achievements of certain milestones.
Can it be the source of the additional cash? I would prefer LS to be already generating enough cash but to be honest I think LS will sell very well but it is still too early for now.
I do not think that they are keeping that pace now.
Volume is less than 300K per day, if shorts cover 1M shares a month it means that about 50K shares per day are bought by shorts to cover which amounts to about 20% of daily volume.
Given the price I would think that much of the buys are slow accumulation or retailers taking positions and not short covering.
I am curious to see next couple of short reports to see if I am right or not.
No sellers & no buyers .... volume is anaemic and everyone is waiting for the next catalyst which should be European and RoW partnerships.
I bet shorts are preparing for these events but I am not sure they will be able to stop NAVB pps this time.
And if they can, well good for long term investors that can ride the final squeeze.